ArticleCureus2026
Occurrence and Clinical Outcomes of Acute Kidney Injury (AKI) Secondary to Acute Pyelonephritis in Hospitalized Patients at Dubai Health Facilities: A Retrospective Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute Kidney Injury (AKI) is a rare but significant complication associated with acute pyelonephritis, which, if left untreated, can cause severe renal impairment, thereby affecting renal structure and function. Upon reviewing the literature, we found that there are limited studies published on the outcomes of acute pyelonephritis. Our study, therefore, aims to evaluate the incidence and clinical outcomes of AKI in patients hospitalized with acute pyelonephritis at tertiary care hospitals under the 'Dubai Health' Institution. We reviewed the medical health records of patients, noting details such as demographic data, risk factors, and vital signs. Out of 303 patients who were hospitalized with acute pyelonephritis, a marked percentage of patients developed AKI. The incidence of acute pyelonephritis (APN) was higher in the female population than in males; however, the incidence of AKI was higher in males than in females, with a median age of 41 years. A strong association between having a positive blood culture and the development of AKI was noted, thereby denoting the fact that patients with bacteremia were more susceptible to AKI. Chronic kidney disease (CKD), current or recent urinary tract catheterization, and emphysematous pyelonephritis were found to be the commonest risk factors for the development of AKI. Outcomes showed that a significant percentage of patients experienced complete resolution of AKI, a minority progressed to CKD, and perhaps only a small percentage succumbed to the illness. AKI is a serious but potentially reversible complication of acute pyelonephritis that requires early recognition and prompt management to prevent long-term renal failure. The Risk, Injury, Failure, Loss, and End-stage (RIFLE) criteria serve as a valuable tool in guiding treatment decisions, particularly regarding the need for renal replacement therapy. Older age, male gender, bilateral involvement, and pre-existing CKD were identified as key risk factors, emphasizing the need for close monitoring and timely antibiotic and supportive therapy in these patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.